Funding for this research was provided by:
National Medical Research Council
Article History
Received: 13 November 2020
Accepted: 15 March 2021
First Online: 25 March 2021
Declarations
:
: Not applicable.
: Not applicable.
: JN receives funding from AstraZeneca for ovarian cancer research. All other authors have no disclosures. All other authors declare that they have no competing interests.